This CME Activity has expired and is no longer available for credit.
Case 2: Influenza Vaccination in a 7-Year-Old Girl With Diabetes and Mild Egg Allergy
Patient Case Study
Time to Complete
March 23, 2012
March 23, 2013
0.75 / AMA PRA Category 1 Credit(s)TM 0.70 / CE for Nurses
Jointly sponsored by Postgraduate Institute for Medicine and Haymarket Medical Education.
If you have any questions relating to the accreditation of this activity, please contact firstname.lastname@example.org.
This activity is supported by an educational grant from MedImmune, LLC.
When a child has a chronic illness and/or egg allergy, the parents may have concerns about the child’s eligibility for influenza vaccination. This case addresses parental questions as to whether mild egg allergy is a contraindication to influenza vaccination and how chronic illness affects the choice of vaccine formulation, as well as the number of doses of influenza vaccine a child should receive.
This activity has been designed to meet the educational needs of pediatricians, pediatric nurse practitioners, pediatric clinical nurse specialists, registered nurses, pediatric office-based registered nurses, and pediatric physician assistants
After taking part in this educational activity, participants should be better able to:
Describe the incidence and burden of pediatric influenza infection
Employ current recommendations for influenza vaccination in pediatric patients
Evaluate the benefits and limitations of the live attenuated influenza vaccine (LAIV) and the trivalent inactivated influenza vaccine (TIV)
Implement strategies to improve parent education about common misconceptions about influenza vaccination
For Registered Nurses: Provide appropriate care and counsel for patients and their families
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Joseph B. Domachowske, MD, Chair Professor of Pediatrics, Microbiology and Immunology State University of New York Upstate Medical University College of Medicine Syracuse, New York
Joseph B. Domachowske, MD, hereby states that he receives fees for non-CME/CE services from GlaxoSmithKline, Merck & Co, MedImmune, LLC, Novartis Pharmaceuticals Corporation, and Sanofi.
Leonard R. Krilov, MD, Faculty Chief, Pediatric Infectious Disease Vice Chairman, Department of Pediatrics Children's Medical Center Winthrop University Hospital Professor of Pediatrics State University of New York Stony Brook School of Medicine Mineola, New York
Leonard R. Krilov, MD, hereby states that he is a consultant for Novartis Pharmaceuticals Corporation. Dr. Krilov receives fees for non-CME/CE services and research grants from GlaxoSmithKline, MedImmune, LLC, and Novartis Pharmaceuticals Corporation.
Concettina Tolomeo, DNP, APRN, FNP-BC, AE-C (CE Reviewer), hereby states that she receives consulting fees from WellTok Inc.
Publishing Staff Disclosure
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
The following PIM planners and managers, Laura Excell, ND, NP, MS, MA, LPC, NCC; Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, CCMEP; Jan Schultz, RN, MSN, CCMEP; and Patricia Staples, MSN, NP-C, CCRN, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
The following Haymarket Medical Education planners and managers hereby state the following financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months: Mary Jo Krey, Senior Project Editor, Lori Marrese, Senior Program Manager, and Kathleen Moore, RN, medical writer, have no real or apparent conflicts of interest to report.
AMA PRA Category 1 Credit(s)TM
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and Haymarket Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE for Nurses
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This educational activity for 0.70 contact hours is provided by Postgraduate Institute for Medicine.
Disclosure of Unlabeled Use
This educational activity may contain discussion of unapproved and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine, MedImmune, LLC, and Haymarket Medical Education, do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Postgraduate Institute for Medicine, MedImmune, LLC, and Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
There are no fees for participating and receiving CME/CE credit for this activity. During the period March 23, 2012 through March 23, 2013, participants must read the learning objectives and faculty disclosures and study the educational activity.
To obtain credit, a score of 70% or better is required. This CME/CE is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.